Coherus BioSciences, Inc. http://www.10gbhost.com/RssFeed/Organization/XgmcXQKhI4er2TIaySqt0A== Contains the last 20 releases Copyright 2021, Coherus BioSciences, Inc. newsdesk@globenewswire.com (NewsDesk) Tue, 02 Feb 2021 13:30:00 GMT webmaster@globenewswire.com (Webmaster) http://www.10gbhost.com/news-release/2021/02/02/2168203/0/en/Coherus-BioSciences-to-Receive-50-million-Strategic-Investment-from-Immuno-Oncology-Partner-Junshi-Biosciences.html http://www.10gbhost.com/news-release/2021/02/02/2168203/0/en/Coherus-BioSciences-to-Receive-50-million-Strategic-Investment-from-Immuno-Oncology-Partner-Junshi-Biosciences.html Nasdaq:CHRS US19249H1032 Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences REDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-oncology collaboration, Coherus BioSciences, Inc. (Nasdaq: CHRS) (“Coherus”) announced that Shanghai Junshi Biosciences Co., Ltd (HK: 1877; SH: 688180) (“Junshi Biosciences”) intends to make a strategic investment of $50 million in Coherus pursuant to the terms of the definitive stock purchase agreement.??

]]>
Tue, 02 Feb 2021 13:30 GMT 2168203 en GlobeNewswire Inc. Coherus BioSciences, Inc. Tue, 02 Feb 2021 13:31 GMT Financing Agreements
http://www.10gbhost.com/news-release/2021/02/01/2167064/0/en/Coherus-BioSciences-to-expand-late-stage-pipeline-to-immuno-oncology-with-in-license-of-Junshi-Biosciences-PD-1-toripalimab-in-United-States-and-Canada.html http://www.10gbhost.com/news-release/2021/02/01/2167064/0/en/Coherus-BioSciences-to-expand-late-stage-pipeline-to-immuno-oncology-with-in-license-of-Junshi-Biosciences-PD-1-toripalimab-in-United-States-and-Canada.html Nasdaq:CHRS US19249H1032 Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada - Coherus to pay $150 million upfront for U.S. and Canada rights to toripalimab, an extensively studied, late-stage anti-PD-1 antibody
- First U.S. BLA filing expected this year for nasopharyngeal carcinoma with breakthrough therapy designation
- Options to PD-1 combination agents, TIGIT and IL-2, add long-term growth potential
- Conference call at 8:00 am Eastern Time today

]]>
Mon, 01 Feb 2021 10:30 GMT 2167064 en GlobeNewswire Inc. Coherus BioSciences, Inc. Mon, 01 Feb 2021 10:30 GMT Partnerships
http://www.10gbhost.com/news-release/2021/01/22/2163047/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2021/01/22/2163047/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective January 21, 2021, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 60,000 shares of the common stock of the Company to 3 newly hired non-officer employees, with a per share exercise price of $17.99, the closing trading price on the grant date.

]]>
Fri, 22 Jan 2021 21:01 GMT 2163047 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 22 Jan 2021 21:01 GMT Directors and Officers Changes in company's own shares
http://www.10gbhost.com/news-release/2021/01/07/2155221/0/en/Coherus-BioSciences-Appoints-Alan-Mendelson-and-Mark-Stolper-to-Board-of-Directors.html http://www.10gbhost.com/news-release/2021/01/07/2155221/0/en/Coherus-BioSciences-Appoints-Alan-Mendelson-and-Mark-Stolper-to-Board-of-Directors.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors REDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the appointments of Alan C. Mendelson and Mark D. Stolper to its Board of Directors effective January 5, 2021.?

]]>
Thu, 07 Jan 2021 21:01 GMT 2155221 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 07 Jan 2021 21:01 GMT Directors and Officers
http://www.10gbhost.com/news-release/2021/01/05/2153796/0/en/Coherus-BioSciences-Management-to-Present-at-the-39th-Annual-J-P-Morgan-Healthcare-Conference.html http://www.10gbhost.com/news-release/2021/01/05/2153796/0/en/Coherus-BioSciences-Management-to-Present-at-the-39th-Annual-J-P-Morgan-Healthcare-Conference.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. EST / 7:50 a.m. PST.

]]>
Tue, 05 Jan 2021 21:01 GMT 2153796 en GlobeNewswire Inc. Coherus BioSciences, Inc. Tue, 05 Jan 2021 21:01 GMT Calendar of Events
http://www.10gbhost.com/news-release/2020/12/21/2148988/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/12/21/2148988/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective December 17, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 66,000 shares of the common stock of the Company to 5 newly hired non-officer employees, with a per share exercise price of $17.78, the closing trading price on the grant date.

]]>
Mon, 21 Dec 2020 21:02 GMT 2148988 en GlobeNewswire Inc. Coherus BioSciences, Inc. Mon, 21 Dec 2020 21:02 GMT Company Announcement
http://www.10gbhost.com/news-release/2020/11/20/2131161/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/11/20/2131161/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective November 19, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 140,500 shares of the common stock of the Company to 10 newly hired non-officer employees, with a per share exercise price of $17.92, the closing trading price on the grant date.

]]>
Fri, 20 Nov 2020 21:01 GMT 2131161 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 20 Nov 2020 21:01 GMT Stock Market News
http://www.10gbhost.com/news-release/2020/11/05/2121488/0/en/Coherus-BioSciences-Reports-Third-Quarter-2020-Financial-Results.html http://www.10gbhost.com/news-release/2020/11/05/2121488/0/en/Coherus-BioSciences-Reports-Third-Quarter-2020-Financial-Results.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Reports Third Quarter 2020 Financial Results – Third Quarter UDENYCA? Net Sales of $113.6 Million –
– Net Income of $27.9 Million –
– Non-GAAP Net Income of $39.7 Million –

]]>
Thu, 05 Nov 2020 21:02 GMT 2121488 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 05 Nov 2020 21:02 GMT Calendar of Events Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2020/10/22/2113227/0/en/Coherus-BioSciences-to-Report-Third-Quarter-Financial-Results-on-November-5th.html http://www.10gbhost.com/news-release/2020/10/22/2113227/0/en/Coherus-BioSciences-to-Report-Third-Quarter-Financial-Results-on-November-5th.html Nasdaq:CHRS US19249H1032 Coherus BioSciences to Report Third Quarter Financial Results on November 5th REDWOOD CITY, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2020 financial results will be released after market close on Thursday, November 5, 2020. Starting at 4:30 p.m. EST, Coherus’ management team will host a conference call to discuss financial results and provide a general business update.

]]>
Thu, 22 Oct 2020 20:15 GMT 2113227 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 22 Oct 2020 20:15 GMT Calendar of Events
http://www.10gbhost.com/news-release/2020/10/16/2109892/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/10/16/2109892/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective October 15, 2020, the compensation committee of the Company’s board of directors granted a newly hired Executive Vice President an option to buy 150,000 shares of the Company’s common stock with a per share exercise price of $18.09, the closing trading price on the grant date, and 10,000 restricted stock units.

]]>
Fri, 16 Oct 2020 13:30 GMT 2109892 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 16 Oct 2020 13:30 GMT Company Announcement
http://www.10gbhost.com/news-release/2020/09/18/2095940/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/09/18/2095940/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective September 17, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 118,000 shares of the common stock of the Company to six newly hired non-officer employees, with a per share exercise price of $19.07, the closing trading price on the grant date.

]]>
Fri, 18 Sep 2020 15:02 GMT 2095940 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 18 Sep 2020 15:01 GMT Health Stock Market News
http://www.10gbhost.com/news-release/2020/08/21/2082006/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/08/21/2082006/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective August 19, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 64,000 shares of the common stock of the Company to seven newly hired non-officer employees, with a per share exercise price of $19.85, the closing trading price on the grant date.

]]>
Fri, 21 Aug 2020 13:30 GMT 2082006 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 21 Aug 2020 13:30 GMT Company Announcement
http://www.10gbhost.com/news-release/2020/08/06/2074566/0/en/Coherus-BioSciences-Reports-Second-Quarter-2020-Financial-Results.html http://www.10gbhost.com/news-release/2020/08/06/2074566/0/en/Coherus-BioSciences-Reports-Second-Quarter-2020-Financial-Results.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Reports Second Quarter 2020 Financial Results – Second Quarter UDENYCA? Net Sales of $135.7 Million –
– Net Income of $59.0 Million –
– Non-GAAP Net Income of $68.3 Million –

]]>
Thu, 06 Aug 2020 20:02 GMT 2074566 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 06 Aug 2020 20:02 GMT Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2020/08/03/2072024/0/en/Coherus-BioSciences-Appoints-Kimberly-Tzoumakas-J-D-to-Board-of-Directors.html http://www.10gbhost.com/news-release/2020/08/03/2072024/0/en/Coherus-BioSciences-Appoints-Kimberly-Tzoumakas-J-D-to-Board-of-Directors.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors REDWOOD CITY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the appointment of Kimberly Tzoumakas, J.D. to its Board of Directors effective July 30, 2020.?

]]>
Mon, 03 Aug 2020 20:48 GMT 2072024 en GlobeNewswire Inc. Coherus BioSciences, Inc. Mon, 03 Aug 2020 20:48 GMT Company Announcement
http://www.10gbhost.com/news-release/2020/07/17/2063929/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/07/17/2063929/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., July 17, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective July 16, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 53,000 shares of the common stock of the Company to four newly hired non-officer employees, with a per share exercise price of $18.30, the closing trading price on the grant date.

]]>
Fri, 17 Jul 2020 13:30 GMT 2063929 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 17 Jul 2020 13:30 GMT Changes in company's own shares
http://www.10gbhost.com/news-release/2020/07/16/2063429/0/en/Coherus-BioSciences-to-Report-Second-Quarter-Financial-Results-on-August-6th.html http://www.10gbhost.com/news-release/2020/07/16/2063429/0/en/Coherus-BioSciences-to-Report-Second-Quarter-Financial-Results-on-August-6th.html Nasdaq:CHRS US19249H1032 Coherus BioSciences to Report Second Quarter Financial Results on August 6th REDWOOD CITY, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2020 financial results will be released after market close on Thursday, August 6, 2020. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call to discuss financial results and provide a general business update.?

]]>
Thu, 16 Jul 2020 13:30 GMT 2063429 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 16 Jul 2020 13:30 GMT Calendar of Events
http://www.10gbhost.com/news-release/2020/06/19/2050732/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html http://www.10gbhost.com/news-release/2020/06/19/2050732/0/en/Coherus-BioSciences-Announces-New-Employment-Inducement-Grants.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Announces New Employment Inducement Grants REDWOOD CITY, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective June 18, 2020, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 93,000 shares of the common stock of the Company to seven newly hired non-officer employees, with a per share exercise price of $16.98, the closing trading price on the grant date.

]]>
Fri, 19 Jun 2020 13:30 GMT 2050732 en GlobeNewswire Inc. Coherus BioSciences, Inc. Fri, 19 Jun 2020 13:30 GMT Company Announcement
http://www.10gbhost.com/news-release/2020/05/07/2029931/0/en/Coherus-BioSciences-Reports-First-Quarter-2020-Financial-Results.html http://www.10gbhost.com/news-release/2020/05/07/2029931/0/en/Coherus-BioSciences-Reports-First-Quarter-2020-Financial-Results.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Reports First Quarter 2020 Financial Results – First Quarter UDENYCA? Net Sales of $116.2 Million –
–Net Income of $35.6 Million –
– Non-GAAP Net Income of $49.8 Million –

]]>
Thu, 07 May 2020 20:08 GMT 2029931 en GlobeNewswire Inc. Coherus BioSciences, Inc. Thu, 07 May 2020 20:08 GMT Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2020/05/04/2026810/0/en/Coherus-BioSciences-Management-to-Present-at-BofA-Securities-2020-Health-Care-Conference.html http://www.10gbhost.com/news-release/2020/05/04/2026810/0/en/Coherus-BioSciences-Management-to-Present-at-BofA-Securities-2020-Health-Care-Conference.html Nasdaq:CHRS US19249H1032 Coherus BioSciences Management to Present at BofA Securities 2020 Health Care Conference REDWOOD CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will make a virtual presentation at BofA Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 1:00 p.m. ET.

]]>
Mon, 04 May 2020 13:30 GMT 2026810 en GlobeNewswire Inc. Coherus BioSciences, Inc. Mon, 04 May 2020 13:30 GMT Calendar of Events
http://www.10gbhost.com/news-release/2020/04/22/2020078/0/en/Coherus-BioSciences-to-Report-First-Quarter-Financial-Results-on-May-7th.html http://www.10gbhost.com/news-release/2020/04/22/2020078/0/en/Coherus-BioSciences-to-Report-First-Quarter-Financial-Results-on-May-7th.html Nasdaq:CHRS US19249H1032 Coherus BioSciences to Report First Quarter Financial Results on May 7th REDWOOD CITY, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that its first quarter 2020 financial results will be released after market close on Thursday, May 7, 2020. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call to discuss financial results and provide a general business update.?

]]>
Wed, 22 Apr 2020 13:30 GMT 2020078 en GlobeNewswire Inc. Coherus BioSciences, Inc. Wed, 22 Apr 2020 13:30 GMT Calendar of Events
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看